Cargando…

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation

Epstein–Barr virus (EBV) predominantly infects B cells and causes B-cell lymphomas, such as Burkitt lymphoma and Hodgkin lymphoma. However, it also infects other types of cells, including T and natural killer (NK) cells, and causes disorders, such as chronic active EBV infection (CAEBV) and T/NK-cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Takuto, Kawazu, Hidetaka, Murata, Takayuki, Iwata, Seiko, Arakawa, Saki, Sato, Yoshitaka, Kuzushima, Kiyotaka, Goshima, Fumi, Kimura, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303147/ https://www.ncbi.nlm.nih.gov/pubmed/24799376 http://dx.doi.org/10.1002/cam4.256

Ejemplares similares

Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma
por: Murata, Takayuki, et al.
Publicado: (2013)

Initial Characterization of the Epstein–Barr Virus BSRF1 Gene Product
por: Yanagi, Yusuke, et al.
Publicado: (2019)

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma
por: Siddiquey, Mohammed NA, et al.
Publicado: (2014)

Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants
por: Gotoh, Kensei, et al.
Publicado: (2011)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production
por: Watanabe, Takahiro, et al.
Publicado: (2017)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Ichikawa, Takaya, et al.
Publicado: (2018)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders
por: Watanabe, Takahiro, et al.
Publicado: (2019)

Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells
por: Ando, Shotaro, et al.
Publicado: (2016)

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma
por: Kimura, Hiroshi, et al.
Publicado: (2021)

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
por: Masud, H. M. Abdullah Al, et al.
Publicado: (2019)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Epstein-Barr virus infection-induced inflammasome activation in human monocytes
por: Torii, Yuka, et al.
Publicado: (2017)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
por: Uddin, Md Kamal, et al.
Publicado: (2023)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein–Barr virus latent membrane protein 2A
por: Ondondo, Beatrice, et al.
Publicado: (2015)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells
por: Sato, Yoshitaka, et al.
Publicado: (2017)

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection
por: Konishi, Natsuno, et al.
Publicado: (2018)

Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
por: Mabuchi, Seiyo, et al.
Publicado: (2021)

Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis
por: Murata, Takayuki
Publicado: (2023)

Estimating the global burden of Epstein–Barr virus-related cancers
por: Wong, Yide, et al.
Publicado: (2021)

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations
por: Fox, Christopher P, et al.
Publicado: (2011)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
por: Inagaki, Tomoki, et al.
Publicado: (2021)

Epstein–Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function
por: Mbiribindi, Berenice, et al.
Publicado: (2020)

Mechanisms of Epstein‐Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma
por: Wang, Jie, et al.
Publicado: (2020)

The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas
por: Suzuki, Michio, et al.
Publicado: (2015)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
por: Liu, Lingzhi, et al.
Publicado: (2019)

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features
por: Kawamoto, Keisuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2k0tnidead9oksgv7nvnqppgj6